Helicobacter pylori induces malignant transformation of gastric epithelial cells in vitro

APMIS

Volumn 119, Issue 3, 2011, Pages 187-197

  Yu, Xiu Wen ^a,b   Xu, Ying ^a   Gong, Yue Hua ^a   Qian, Xu ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Cell transformation; GES 1 cell; Helicobacter pylori; Intestinal phenotypes of gastric cancers

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIVATING TRANSCRIPTION FACTOR 4; BETA CATENIN; KI 67 ANTIGEN; MESSENGER RNA; UVOMORULIN;

ARTICLE; BACTERIAL STRAIN; CARCINOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; COCULTURE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH EPITHELIUM; TUMOR GENE;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CADHERINS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR STEM CELL ASSAY;

EID: 79551469154     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02709.x     Document Type: Article

References (41)

1. Naumann M, Crabtree JE. Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol 2004;12:29-36.
2. Centre international de recherche sur le cancer. Schistosomes, liver flukes and helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
3. Li GL, Chen WQ. Representativeness of population-based cancer registration in China - comparison of urban and rural areas. Asian Pac J Cancer Prev 2009;10:559-64.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
5. Peek RM Jr, Wirth HP, Moss SF, Yang M, Abdalla AM, Tham KT, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000;118:48-59.
6. Mizoshita T, Tsukamoto T, Toyoda T, Ban H, Nozaki K, Tatematsu M, et al. Intestinal phenotypes of stomach cancers arising after Helicobacter pylori eradication in carcinogen-treated Mongolian gerbils. Asian Pac J Cancer Prev 2007;8:267-71.
7. Takenaka Y, Tsukamoto T, Mizoshita T, Cao X, Ban H, Ogasawara N, et al. Helicobacter pylori infection stimulates intestinalization of endocrine cells in glandular stomach of Mongolian gerbils. Cancer Sci 2006;97:1015-22.
8. Mizoshita T, Tsukamoto T, Takenaka Y, Cao X, Kato S, Kaminishi M, et al. Gastric and intestinal phenotypes and histogenesis of advanced glandular stomach cancers in carcinogen-treated, Helicobacter pylori-infected Mongolian gerbils. Cancer Sci 2006;97:38-44.
9. Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara Y, et al. Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Jpn J Cancer Res 2002;93:374-81.
10. Bhasin DK, Kakkar N, Sharma BC, Joshi K, Sachdev A, Vaiphei K, et al. Helicobacter pylori in gastric cancer in India. Trop Gastroenterol 1999;20:70-2.
11. Ito M, Tanaka S, Kamada T, Haruma K, Chayama K. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol. 2006;12(1):10-16.
12. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, et al. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 2006;118:649-57.
13. Martinez-Madrigal F, Ortiz-Hidalgo C, Torres-Vega C, Alvarez L, Manzo-Montaño A, García-López L, Esquivel-Ayanegui F. Atypical regenerative changes, dysplasia, and carcinoma in situ in chronic gastritis associated with Helicobacter pylori. Rev Gastroenterol Mex 2000;65:11-17.
14. Arista-Nasr J, Jimenez-Rosas F, Uribe-Uribe N, Herrera-Goepfert R, Lazos-Ochoa M. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas. Am J Gastroenterol 2001;96:1746-50.
15. Clements WM, Wang J, Sarniak A, Kim OJ, MacDonald J, Fenoglio-Preiser C, et al. β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002;62:3503-6.
16. Ogasawara N, Tsukamoto T, Mizoshita T, Inada K, Cao X, Takenaka Y, et al. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 2006;49:612-21.
17. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 1999;59:4257-60.
18. Morohara K, Tajima Y, Nakao K, Nishino N, Aoki S, Kato M, et al. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol 2006;132:363-75.
19. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002;161:611-18.
20. Kim SK, Jang HR, Kim JH, Kim M, Noh SM, Song KS, et al. CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers. Carcinogenesis 2008;29:1623-31.
21. Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res 2009;69:2050-6.
22. Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009:1545-55.
23. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001;344:1904-9.
24. Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004;203:681-7.
25. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, et al. Frequent loss of membranous E-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of β-catenin. Clin Exp Metastasis 2005;22:85-93.
26. He H, Gong Y, Yuan Y. Damage effect of different genotype of Helicobacter pylori on human gastric epithelial cell line GES-1 in high- and low-risk areas of gastric cancer. World Chin J Digestol 2005;13:2681-4.
27. Ke Y, Ning T, Wang B. Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1. Zhonghua Zhong Liu Za Zhi 1994;16:7-10.
28. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 2002;99:10084-9.
29. Ebert MP, Fei G, Kahmann S, Müller O, Yu J, Sung JJ, et al. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002;23:87-91.
30. Poser I, Golob M, Weidner M, Buettner R, Bosserhoff AK. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res 2002;62:5962-6.
31. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, et al. Regulation of cyclooxygenase-2 expression by the wnt and ras pathways. Cancer Res 2003;63:728-34.
32. Chiba T, Marusawa H, Seno H, Watanabe N. Mechanism for gastric cancer development by Helicobacter pylori infection. J Gastroenterol Hepatol 2008;23(8 Pt 1):1175-81.
33. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009;15:971-6.
34. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007;11:2.
35. Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer 2009;124:434-9.
36. Terrés AM, Pajares JM, O'Toole D, Ahern S, Kellher D. H. pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol 1998;51:410-12.
37. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007;26:4617-26.
38. Weydig C, Starzinski-Powitz A, Carra G, Löwer J, Wessler S. CagA-independent disruption of adherencejunction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp Cell Res 2007;313:3459-71.
39. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003;300:1430-4.
40. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009;5:23-34.
41. Sokolova O, Bozko PM, Naumann M. Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem 2008;283:29367-74.